EULAR Journals
Latest News
- EULAR proudly announces the launch of its new open-access journal, EULAR Rheumatology Open (ERO), a pioneering platform dedicated to advancing research and knowledge in the field of rheumatology. The journal will be launched in January 2025. offering an innovative, online-only space hosted by the globally renowned publisher Elsevier. ERO will provide researchers, healthcare professionals, and the wider scientific community with immediate access to the latest advancements in rheumatology.
Read the EULAR Press Release here - EULAR announces a new partnership with Elsevier, a global leader in information and analytics, to publish its flagship scientific journal, Annals of the Rheumatic Diseases (ARD). The journal will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2025.
Read the EULAR Press Release here - EULAR and BMJ announce change of
ownership of leading rheumatology journals, Annals
of the Rheumatic Diseases (ARD) and RMD
Open. EULAR will take full
ownership of ARD, while BMJ will
wholly own RMD Open.
Read the joint announcement here
EULAR Rheumatology Open (ERO)
EULAR proudly announces the launch of its new open-access journal, EULAR Rheumatology Open (ERO), a pioneering platform dedicated to advancing research and knowledge in the field of rheumatology. The journal offers an innovative, online-only space hosted by the globally renowned publisher Elsevier. ERO provides researchers, healthcare professionals, and the wider scientific community with immediate access to the latest advancements in rheumatology.
The new journal represents EULAR's commitment to fostering scientific excellence and promoting the dissemination of high-quality, peer-reviewed research. As an open-access journal, it ensures that cutting-edge studies, reviews, and insights are freely available to a global audience, furthering the reach and impact of rheumatology research across disciplines.
Annals of the Rheumatic Diseases (ARD)
Annals of the Rheumatic Diseases (ARD) is an international peer reviewed journal committed to promoting the highest standards of scientific exchange and education. It is the leading rheumatology journal publishing a combination of high-quality scientific papers, including original research, reviews, recommendations, viewpoints, and more. Clinical, basic and translational science across the inflammatory and non-inflammatory musculoskeletal conditions are part and parcel of this spectrum.
ARD is an official journal of EULAR with an impact factor of 20.3.
Related Videos
Related Information
ARD lay summaries for patients and non-clinicians
ARD provides short research summaries for patients and non-clinicians to accompany selected key research papers published in the journal. These aim to clearly explain the results of the research studies as well as any implications for treatment of the specific condition. The summaries are written in plain language in a consistently structured format and checked for accuracy and readability by expert rheumatologists and people from EULAR’s network of patient research partners.
Latest News
- EULAR announces a new partnership with Elsevier, a global leader in information and analytics, to publish its flagship scientific journal, Annals of the Rheumatic Diseases (ARD). The journal will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2025.
Read more
- EULAR and BMJ announce change of ownership of leading rheumatology journals, Annals of the Rheumatic Diseases (ARD) and RMD Open. EULAR will take full ownership of ARD, while BMJ will wholly own RMD Open.
Read more
Journals on social media
You can follow the journal on and listen to free occasional audio podcasts from ARD .